levofloxacin has been researched along with Infections, Mycobacterium in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
Disratthakit, A; Doi, N | 1 |
Aozasa, N; Fukano, H; Ishii, N; Miyamoto, Y; Murakami, T; Nakamura, K; Tsunemi, Y | 1 |
Ishikawa, S; Mukai, Y; Paudel, S; Suga, S; Wada, T; Yoshida, S | 1 |
Brade, V; Enzensberger, R; Gruschke, A | 1 |
5 other study(ies) available for levofloxacin and Infections, Mycobacterium
Article | Year |
---|---|
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.
Topics: Aminopyridines; Antitubercular Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections; Mycobacterium kansasii; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Ofloxacin; Quinolines; Rifampin; Species Specificity | 2010 |
Successful treatment of cutaneous Mycobacterium chelonae infection by switching from levofloxacin to sitafloxacin.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Levofloxacin; Mycobacterium chelonae; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial | 2023 |
INTENSIVE TREATMENT OF A CAPTIVE BORNEAN ELEPHANT (
Topics: Administration, Rectal; Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Elephants; Isoniazid; Japan; Levofloxacin; Mycobacterium; Mycobacterium Infections; Pyrazinamide | 2021 |
[Osteomyelitis of the tibial head caused by Mycobacterium haemophilium in a patient with AIDS].
Topics: Abscess; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Mycobacterium haemophilum; Mycobacterium Infections; Ofloxacin; Osteomyelitis; Recurrence; Rifabutin; Tibia | 2002 |